Serine analogs of bu-3608 antibiotics
CA 2001714 C · Owner: Bristol-Myers Company · Inventors: Miyaki, Takeo; Kakushima, Masatoshi; Oki, Toshikazu
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed are antibiotics BU-3608 FA-1 and FA-2 and alkyl derivatives thereof. These compounds are useful as antifungal agents. BU-3608 FA-1 and FA-2 are produced from Actinomadura hibisca in a medium containing a source of D-serine.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 27, 1989 and granted January 26, 1999. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended October 27, 2009.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 27, 2011.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.